Robert Lanza Appointed Editor-in-Chiefof BioResearch Open Access journal

PRLog (Press Release) - Feb. 11, 2013 - Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com

Robert Lanza Appointed Editor-in-Chiefof BioResearch Open Access journal

New Rochelle, NY, February 11, 2013—Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com) is pleased to announce the appointment of Robert Lanza, MD as Editor-in-Chief of BioResearch Open Access effective immediately. Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, will continue in her role as Editor. The Journal, in its second year of publication, is a fully peer-reviewed open access journal for the rapid-publication of a broad range of scientific topics including stem cells, molecular and cellular biology, tissue engineering and biomaterials, bioengineering, gene therapy, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and available on the BioResearch Open Access website (http://www.liebertpub.com/biores).

Dr. Lanza is Chief Scientific Officer at Advanced Cell Technology and Adjunct Professor at Wake Forest University School of Medicine. He has hundreds of publications and inventions, and over 30 scientific books. Dr. Lanza was a Fulbright Scholar and published the first-ever report of human embryonic stem cells transplanted into human patients. Recently, Lanza and a team lead by Kwang-Soo Kim at Harvard University reported a safe method for generating induced pluripotent stem (iPS) cells. This new method provides a potentially safe and non-controversial source of patient-specific stem cells for translation into the clinic. Dr. Lanza has received numerous awards, including an NIH Director’s Award for “Translating Basic Science Discoveries into New and Better Treatments,” and the 2010 “Movers and Shakers” Who Will Shape Biotech Over the Next 20 Years (BioWorld, along with Craig Venter and President Barack Obama).

Journal section editor luminaries in different disciplines:  James M. Wilson, MD, PhD, University of Pennsylvania; Antonios G. Mikos, PhD, Rice University; Professor Sir Ian Wilmut, OBE FRS FRSE, University of Edinburgh; Peter C. Johnson, MD, Scintellix, LLC, Raleigh, NC; Aubrey D.N.J. de Grey, PhD, SENS Foundation, Cambridge, UK; Alan J. Russell, PhD, Carnegie Mellon University; Thomas Hope, PhD, Northwestern University; Bruce A. Sullenger, PhD, Duke University Medical Center; Graham C. Parker, PhD, Wayne State University School of Medicine; Carol Shoshkes Reiss, PhD, New York University; Stephen C. Ekker, PhD, Mayo Clinic, Rochester, MN; John B. West, MD, PhD, University of California, San Diego; David L. Woodland, PhD, Chief Scientific Officer, Keystone Symposia on Molecular and Cellular Biology; and Eugene Kolker, PhD, Seattle Children's Hospital, among others.

About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Assay and Drug Development Technologies, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (http://www.liebertpub.com).

Photo:
http://www.prlog.org/12077423/1